>

Theodore Samuels - Perrigo Company Independent Director

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 40px;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  Director
Mr. Theodore R. Samuels is an Independent Director of the Company. From 1981 to 2017, Mr. Samuels was an investor at Capital Group, a financial services company, and he served as President of Capital Guardian Trust Company, an affiliated company of Capital Group, from 2010 to 2016. While at Capital Group, he also served on The Capital Group board, audit committee and finance committee, as well as on numerous management and investment committees. Mr. Samuels was a director for Stamps.com since January 2017 and a director of BristolMyers Squibb since February 2017.
Age: 63  Director Since 2017      
353 1 709 4000  http://www.perrigo.com

Theodore Samuels Latest Insider Activity

Theodore Samuels over six months ago via Macroaxis 
Perrigo Company exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Omkar GoswamiDr Reddys Laboratories Ltd
2000
Allan ObermanDr Reddys Laboratories Ltd
2019
Louise ParentZoetis
2013
Sridar IyengarDr Reddys Laboratories Ltd
2011
Leo PuriDr Reddys Laboratories Ltd
2018
William YoungVertex Pharmaceuticals Incorpor
2014
Alfred GilmanRegeneron Pharmaceuticals
1990
Bharat DoshiDr Reddys Laboratories Ltd
2016
Min TangOrigin Agritech Limited
2009
Gregory NordenZoetis
2013
Paul BisaroZoetis
2015
Joseph GoldsteinRegeneron Pharmaceuticals
1991
Hans HaslerDr Reddys Laboratories Ltd
2016
Anupam PuriDr Reddys Laboratories Ltd
2002
Prasad MenonDr Reddys Laboratories Ltd
2019
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Willie ReedZoetis
2014
Sanjay KhoslaZoetis
2013
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Arthur RyanRegeneron Pharmaceuticals
2003
Bonnie BasslerRegeneron Pharmaceuticals
2016

Company Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, PresidentView
Gary Cohen, Independent DirectorView
Arthur Shannon, IR Contact OfficerView
Ronald Winowiecki, Acting CFOView
Svend Andersen, Executive Vice President and President - Consumer Healthcare InternationalView
Judy Brown, CFO and Executive VPView
Laurie Brlas, Independent DirectorView
Donal OConnor, Independent DirectorView
James Michaud, Chief Human Resource Officer, Executive Vice PresidentView
Louis Yu, Executive Vice President - Global QualityView
John Wesolowski, Executive Vice President and Presidentident - RXView
Theodore Samuelsto, Independent DirectorView
Scott Jamison, Executive Vice President General Manager - NutritionalsView
Ellen Hoffing, Independent DirectorView
Marc Coucke, Executive Vice President General Manager - Omega Pharma BusinessView
Adriana Karaboutis, Independent DirectorView
Michael Jandernoa, Independent DirectorView
Paul Weninger, Executive Vice President - Global Quality OperationsView
Thomas Farrington, Senior Vice President CIOView
Herman Morris, Independent DirectorView
Jeffrey Needham, Executive Vice President General Manager - Consumer HealthcareView
Todd Kingma, Executive VP, General Counsel and SecretaryView
Rolf Classon, Independent DirectorView
Raymond Silcock, CFOView
Shlomo Yanai, Independent Director NomineeView
Jatin Shah, Senior Vice President Chief Scientific OfficerView
Michael Stewart, Senior Vice President - Global Human ResourcesView
Jeffrey Kindler, Independent DirectorView
Jacqualyn Fouse, Independent DirectorView
Grainne Quinn, Executive Vice President Chief Medical OfficerView
Theodore Samuels, Independent DirectorView
Geoffrey Parker, Independent DirectorView
Murray Kessler, President CEO, DirectorView
Sharon Kochan, Executive VP and General Manager of InternationalView
Gary Kunkle, Lead Independent DirectorView
Joseph Papa, Chairman and CEOView
Marry Brlas, Independent Chairman of the BoardView
Bradley Alford, Independent DirectorView
Jeffrey Smith, Independent DirectorView
Bradley Joseph, IR Contact OfficerView
James Dillard, Executive Vice President Chief Scientific OfficerView
Douglas Boothe, Executive Vice President General Manager - Rx PharmaceuticalsView
Ronald Janish, Executive Vice President - Global Operations and Supply ChainView
Uwe Rohrhoff, President CEO, DirectorView

Stock Performance Indicators

Return On Equity4.32
Return On Asset2.19
Profit Margin5.23
Operating Margin16.61
Current Valuation11.27 B